Pharmacokinetic Study of ARALAST (Human Alpha1- PI)

Clinical trial NCT00242385 · COMPLETED

Trial details

NCT number: NCT00242385
Sponsor: Baxalta now part of Shire
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Alpha 1-Antitrypsin Deficiency

Start date: 2005-12-20
Primary completion: 2006-06-05
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.